- About SHS
- Clinical Services
- Prevention & Wellness
- Survivor Care & Advocacy
- Fees, Insurance & Forms
- Fees for Services
- Medical Records and Referrals
Oregon State University requires ALL OSU Corvallis students age 25 and under to be vaccinated against Meningococcal B disease (MenB).
Students must have two doses of Bexsero® or three doses of Trumenba® and provide documentation after each dose.
OSU is requiring Meningococcal B vaccines for all Corvallis campus students age 25 and under because there have been six cases of OSU Corvallis students being diagnosed with Meningococcal B disease since November 2016.
Though uncommon, MenB disease is very serious. The disease can kill 10-15 percent of those who develop it. It can leave 20 percent with a permanent disability, such as loss of hearing or sight, loss of a limb, or permanent deficit in mental function.
While many OSU students already have been immunized, in consultation with OSU, state and local health authorities determined stronger measures were necessary to ensure students are vaccinated.
The MCV4 vaccine protects against serogroups A, C, W and Y of meningococcal disease. It does not protect against meningococcal B disease. Alternately, MenB vaccine does not protect against serogroups A, C, Y, and W.
The best way to protect yourself against meningococcal disease is to receive both the meningococcal B (MenB) vaccine and the quadrivalent (MCV4) meningococcal vaccine.
The MenB vaccine requires either two or three doses, depending on the brand used. The quadrivalent MCV4 meningococcal vaccine requires just one dose.
If you do not comply with this requirement, you will have an academic hold.
Yes. Oregon State University has authority under state law to adopt certain immunization requirements. OSU’s MenB vaccination requirement complies with state law as both medical and non-medical exemptions are available and the requirement is informed by the current recommendations authored by the Centers for Disease Control (CDC).
Based on guidance from the Centers for Disease Control (CDC), Benton County and Oregon Health Authority public health officials say that students 25 years of age and under, particularly those who live in congregate housing, or are members of campus fraternal organizations or athletic teams, are most at risk of contracting MenB disease. During previous outbreaks of meningococcal disease at other universities nationally, employees have not been found to be at generally increased risk, due possibly to their limited exposure to students. Employees may want to consult their medical providers regarding the risk of MenB and to determine if vaccination is advisable.
Note: on-campus vaccinations are only available for registered students.
In compliance with state law, both medical and non-medical exemptions are available to OSU’s MenB immunization requirement.
I believe I have a medical condition that should exempt me from the MenB vaccine. What should I do?
I believe I am eligible for a non-medical exemption. What should I do?
Call Student Health Services at 541-737-2724 with questions about:
Call your insurance carrier if you have questions about insurance benefits or coverage.
Ideally, you will begin your vaccinations at home with your in-network healthcare provider and arrive on the Corvallis campus fully immunized against MenB. If you do not finish the series before arriving at OSU, you can finish either series at Student Health Services, the OSU Pharmacy, or with a local urgent care or pharmacy.
New fall 2018 students age 25 and under are required to have the Meningococcal B vaccine.
A list of Samaritan Health Services clinics that provide walk-in MenB vaccines:
NOTE: The Oregon Legislature now requires Oregon-based private insurance plans to cover MenB vaccinations. If you have problems obtaining coverage through your Oregon insurer, contact the state of Oregon's Office of Patient Advocates at 1-888-877-4894 or email firstname.lastname@example.org
The vaccine must be paid for by you or your insurance provider. If you are uninsured or concerned about your ability to pay, come to the SHS immunization office on the first floor of the Plageman Building, 108 SW Memorial Place, where people will help you with additional resources.
If you are uninsured or concerned about your ability to pay, come to Student Health Services where people will help you with additional resources.
Students who are Oregon residents and meet eligibility criteria may be able to enroll in the Oregon Health Plan (OHP). This plan will provide no- or low-cost health coverage.
For questions about OHP enrollment, please call the Health Navigators at Benton County Health Department at 541-766-2130.
If you receive your vaccination at any of the following locations, you do not need to submit additional documentation:
If you received your MenB vaccination(s) at a different location you must provide written documentation—such as a pharmacy receipt, a vaccination record from your healthcare provider, or other documentation—to the university. Your name and student ID number must be included with documentation so the information is recorded correctly.
Submit your MenB vaccination documentation in any of the following ways:
Submit your MenB medical or non-medical exemption documentation by:
Check the patient portal.
Or call the immunization office at 541-737-7573.
If you are a resident of Oregon or if you have received any vaccines in Oregon:
Call 541-737-7570. Student Health Services staff will check the Oregon Alert Immunization Registry on your behalf.
If you received vaccines in a state other than Oregon:
If you received vaccines at your primary care clinic:
Call your primary care provider directly to request that your immunization record be sent to OSU's confidential Student Health Services fax line (541-306-6670).
If it has been more than 28 days since your most recent dose of vaccine, you may receive the required follow-up dose from:
You are advised to call ahead to ensure the vaccine is available. Most providers can obtain the vaccine in a day or two.
If you have health insurance through OSU’s sponsored plan, carried by Aetna, you may receive your vaccine at Student Health Services. Check in at the Plageman Building, room 118.
If you have health insurance through OSU’s sponsored plan, carried by PacificSource, you may receive your vaccine at Student Health Services. Check in at the Plageman Building, room 118.
MenB is transmitted through exposure to the saliva of an infected individual through behavior such as sharing drinking glasses, makeup, utensils, or smoking devices and by intimate contact such as kissing.
It can be shared through prolonged, close contact with someone who is infected, such as spending several hours together in a car or dorm room together.
Most people infected with MenB do not become ill but they can still infect others. These people are called asymptomatic or healthy carriers. There may be hundreds of these healthy carriers on campus. People can carry the bacteria in their throat for several weeks and eventually eliminate it through their immune system. Even though these people are not ill, they are the main source for spreading the infection to others. There is no way to know if you are a healthy carrier. Neither vaccines nor antibiotics eliminate the carrier state.
Being immunized is the best way to prevent yourself from getting Meningococcal B disease.
To avoid being infected:
Individuals with MenB disease typically develop a high fever, severe headache, stiff neck, and body aches. They may experience vomiting, a rash, and extreme fatigue. These symptoms usually progress very quickly over 24 hours. Anyone with these symptoms should go to a healthcare provider immediately.
If you have severe symptoms:
If you have less severe symptoms:
Your primary care provider or a clinician might be following standard MenB disease recommendations. The recommendations are different in situations where a Meningococcal B disease outbreak has been declared, such as it has been on the OSU Corvallis campus.
The biggest discrepancy in advice is likely to be as it regards the Trumenba® vaccine series. The standard recommendation is for patients to receive two shots of Trumenba® given six months apart. In the case of a MenB disease outbreak, a two-dose protocol does not provide sufficient immunity soon enough.
For this reason, OSU requires three shots of Trumenba®. Two of those doses must be received at least 28 days apart. The third dose must be received at least six months following the first dose.
Both vaccines are still effective in producing immunity, even when doses are given later than the recommended interval. Do not restart the vaccine series. Just complete receiving your remaining dose(s). This is true even if you are several weeks or months late for your second Bexsero® or Trumenba® dose, or even the third Trumenba® dose.
NO. If doses are received too soon, you will not be adequately immunized.
No. You must use the same brand of vaccine to complete either a two-dose series of Bexsero® or a three-dose series of Trumenba®.